OMER - Omeros Corporation (OMER) Q1 2024 Earnings Call Transcript
2024-05-15 19:23:04 ET
Omeros Corporation (OMER)
Q1 2024 Earnings Conference Call
May 15, 2024 4:30 PM ET
Company Participants
Jennifer Williams - Investor Relations
Greg Demopulos - Chairman and Chief Executive Officer
Mike Jacobsen - Chief Accounting Officer
Andreas Grauer - Chief Medical Officer
Steve Whitaker - Vice President-Clinical Development
Nadia Dac - Chief Commercial Officer
Catherine Melfi - Chief Regulatory Officer
Conference Call Participants
Steve Brozak - WBB Securities
Olivia Brayer - Cantor Fitzgerald
Presentation
Operator
Good afternoon and welcome to today's earnings call for Omeros Corporation. At this time all participants are in listen-only mode. After the company's remarks we will conduct a question-and-answer session. Please be advised that this call is being recorded at the company's request. And a replay will be available on the company's website for one week from today.
I'll now turn the call over to Jennifer Williams, Investor Relations for Omeros.
Jennifer Williams
Good afternoon and thank you for joining the call today. I'd like to remind you that some of the statements that will be made on the call today will be forward-looking. These statements are based on management's beliefs and expectations as of today only and are subject to change.
All forward-looking statements involve risks and uncertainties that could cause the company's actual results to differ materially, please refer to the special note regarding forward-looking statements in the company's quarterly report on Form 10-Q, which was filed today with the SEC, and the risk factor section of the company's most recent annual report on Form 10-K for a discussion of these risks and uncertainties....
Omeros Corporation (OMER) Q1 2024 Earnings Call Transcript